kwic
low
low
right
off
ON
144
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for low out of >500 occurrences
318584 occurrences (No.68 in the rank) during 5 years in the PubMed. [no cache] 500 found
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to low]
318584 occurrences (No.68 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 144) Conversely, all the novel methods obtained higher sensitivities allowed reaching as low as 2.5-1.2% of the mutated DNA.The study demonstrates that early conventional methods could likely have underestimated the prevalence of KIT mutations of MCTs, therefore affecting the assessment of their relevance in prognosis and tyrosine kinase inhibitor (TKI) treatment effectiveness. |
| PMID:23654224 DOI:10.1111/vco.12039 |
| 2015 Veterinary and comparative oncology |
| * The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection of c-KIT somatic mutations in canine mast cell tumours. |
| - The conventional polymerase chain reaction (PCR)/sequencing methods may be poorly suited for the detection of somatic mutations in canine mast cell tumour (MCT) samples owing to limited sensitivity. This study was aimed at establishing novel and more sensitive methods, assessing their limit of detection and comparing their sensitivity with conventional methods.Two different 'driver' somatic mutations of c-KIT, together with the wild-type counterparts, were cloned in plasmids to prepare standard samples with known concentrations of mutated alleles in a background of wild-type alleles; the plasmids standards were assayed using either conventional or novel, highly sensitive technique. Conventional PCR/sequencing showed a sensitivity of 50-20%. Conversely, all the novel methods obtained higher sensitivities allowed reaching as low as 2.5-1.2% of the mutated DNA.The study demonstrates that early conventional methods could likely have underestimated the prevalence of KIT mutations of MCTs, therefore affecting the assessment of their relevance in prognosis and tyrosine kinase inhibitor (TKI) treatment effectiveness. |
[
right
kwic]
(1)21  and |
(18)4 or |
(35)2 Chilean |
(52)2 energy |
| (2)19 laser |
(19)4 socioeconomic |
(36)2 HLB |
(53)2 families |
| (3)11 doses |
(20)3 Er:YAG |
(37)2 OAs |
(54)2 genetic |
| (4)11 levels |
(21)3 O2 |
(38)2 acculturation |
(55)2 group |
| (5)10 *null* | (22)3 PFR |
(39)2 activities |
(56)2 maternal |
| (6)10 cost |
(23)3 PbB |
(40)2 activity |
(57)2 method |
| (7)10 lipoprotein |
(24)3 STT |
(41)2 after |
(58)2 molecular |
| (8)8 back |
(25)3 concentrations |
(42)2 areas |
(59)2 oral |
| (9)8 birth |
(26)3 educational |
(43)2 at |
(60)2 pH |
| (10)8 dose |
(27)3 features |
(44)2 bioavailability |
(61)2 peer |
| (11)7 in |
(28)3 risk |
(45)2 body |
(62)2 population |
| (12)7 level |
(29)3 serum |
(46)2 cancer |
(63)2 radiation |
| (13)6 birthweight |
(30)3 shear |
(47)2 children |
(64)2 resilience |
| (14)5 but |
(31)3 tumours |
(48)2 coverage |
(65)2 running |
| (15)4 as |
(32)3 vagal |
(49)2 degree |
(66)2 sensitivity |
| (16)4 carbon |
(33)3 water |
(50)2 density |
(67)2 settings |
| (17)4 income |
(34)3 whole-body |
(51)2 education |
(68)2 temperature |
add keyword
--- WordNet output for low ---